Efficacy/effectiveness Administration Newborn (0-1 years) Children (2-9 years) Tuberculosis Diphtheria Tetanus Pertussis Measles
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Economic aspects Newborn (0-1 years) Children (2-9 years) Haemophilus influenzae type B
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Rotavirus
Economic aspects Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Adults (18+) Elderly (65+) Haemophilus influenzae type B
Safety Administration Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Parents/caregivers Mumps Measles Rubella
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus